amylin glp-1 dual agonist Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Combined Amylin/GLP-1 pharmacotherapy to promote
Description
Major players like Novo Nordisk, Eli Lilly, and AstraZeneca are making strategic investments
Take our survey
01176-6/asset/8f252412-ab10-4527-8c33-9679c4f31f6c/main.assets/gr3_lrg.jpg)
Effectiveness: How Alternatives Compare Understanding how different alternatives compare in real-world effectiveness helps set appropriate expectations
Cell Metab 2006;3:15365
Drivers of Recent Interest in GLP-1RA Though GLP-1RAs have been available for close to 20 years, there has been a surge in recent interest amongst the business community
Plus the extended results are still being analysed, so there is still work to be done
